Concepedia
Statistics
Publications
13
Citations
872
H-Index
12
Active since
2010
Affiliations
Bayer (Norway)(Current)
Bayer (Germany)
657 Oslo
General Electric (Norway)
University of Wuppertal
Roger M. Bjerke is an author at Bayer (Norway) specializing in medicine, oncology, and targeted therapy.
Publications per year
2010–2024
Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met
Jacobus Burggraaf, Ingrid M. C. Kamerling, Paul B. Gordon et al. · Nature Medicine · 2015 · 295 citations · Full text
Medicine, Oncology, Pharmacology +13
Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
Stefanie Hammer, Urs B. Hagemann, Sabine Zitzmann-Kolbe et al. · Clinical Cancer Research · 2019 · 121 citations · Full text
Medicine, Oncology, Pharmacology +17
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers
Urs B. Hagemann, Christine Ellingsen, Joachim Schuhmacher et al. · Clinical Cancer Research · 2019 · 108 citations
<i>In Vitro</i> and <i>In Vivo</i> Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia
Urs B. Hagemann, Katrine Wickstroem, Ellen Wang et al. · Molecular Cancer Therapeutics · 2016 · 80 citations
Targeted alpha therapy using a novel CD70 targeted thorium-227 conjugate in<i>in vitro</i>and<i>in vivo</i>models of renal cell carcinoma
Urs B. Hagemann, Dessislava Mihaylova, Steinar Uran et al. · Oncotarget · 2017 · 51 citations · Full text
Medicine, Oncology, Pharmacology +14
1–5 of 13